Reaction
Cutis Laxa reporting signals
As of the last recalculation, Cutis Laxa appears in 268 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 91.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 28 | 91.4 | 91.5 |
| Onabotulinumtoxina | 21 | 22.8 | 22.8 |